During 7-13 November, 2012 Farmak JSC was inspected by FDA* to ascertain that Validol tablets are manufactured for the U.S. market in compliance with the cGMP requirements.
Our Company has received a formal response saying that the inspection procedures are completed and Validol-related Production and Quality Systems are assessed as acceptable.
Olga Oleksiichuk, Quality Director says, “For Farmak, it was the first positive experience passing an FDA inspection, during which our specialists could observe FDA’s approaches to interrelated assessment of the six quality systems, including, quality assurance, production, quality control, maintenance and other systems. We saw that the major focus of FDA inspection was given to the issues that pose the biggest consumer safety concern”.
Our specialists have also gained valuable experience of communication with the inspectors and saw how important professionalism and teamwork are. At the same time, we are responsible to assure the continued compliance with the current Good Manufacturing Practice (сGMP).
On February 11, 2021 the Kyiv City Council resolved to sell a land plot to Farmak plant. The resolution was adopted by an absolute majority vote. It concerns the territory where the Kyiv Chemical and Pharmaceutical Plant has been located for 95 years. According to the document, the intended purpose of the land plot is […]
The Press Center’s standpoint for the mass media Farmak plant in Kyiv faces a targeted information attack now. Those who have organized a wave of publications most probably pursue the purpose of manipulating public opinion and deputies of the Kyiv City Council in order to clear a land plot in Podol for yet another construction. […]
In accordance with Decree of the President of Ukraine No. 24/2021 On Granting State Awards on Occasion of the Unity Day of Ukraine Hryhorii Viktorovych Kostiuk, member of the Supervisory Board of Joint Stock Company Farmak, has been awarded the title “Honoured Worker of Pharmacy of Ukraine”. The award has been granted for significant personal [&hellip...